Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL1700123	静注人免疫球蛋白（10%）	human immunoglobulin(PH4)	Injection	Biological Products(7)	New Drug Application	2017-12-07	贵州泰邦生物制品有限公司	Guizhou Taibang Biological Products Co Ltd	Certificate Issued	2018-11-09	view
CXSL2101366	静注人免疫球蛋白（10%）	human immunoglobulin(PH4)	Injection	Biological Products(3.2)	New Drug Application	2021-10-14		China Resources Boya Bio-pharmaceutical Group Co Ltd			view
CYSB2200240	静注人免疫球蛋白（10%）	human immunoglobulin(PH4)	Injection	Biological Products	Supplementary Application	2022-10-10		Guizhou Taibang Biological Products Co Ltd			view